Dr. Nigel Gale brings science, systems thinking, and serious cultivation credibility to the podcast.
In this episode, Nikita Cretu sits down with Dr. Nigel Gale, Director of Grow and Production at Nova Soma, an EU GMP certified cannabis production facility operating under Somi in Portugal. A PhD botanist trained at the University of Toronto under one of the leading plant scientists of his generation, Nigel has carved out a rare career at the intersection of academic rigour and commercial cultivation. From doubling yields without spending a single dollar, to debunking some of the cannabis industry’s most contested growing myths, this episode covers the full breadth of what it takes to lead a high-performance cultivation operation in today’s regulated European market.
Key Highlights and Insights
The Ecosystem Approach to Leadership
Nigel’s first move at any new facility is not to spend money; it is to understand the system. Plants, environment, and people interact as a single ecosystem, and real impact comes from identifying and unravelling the one bottleneck that is quietly limiting everything else. At Nova Soma, this approach delivered doubled yields with zero additional capital expenditure.
Operational Transparency and Congruence
From the CEO to the floor sweeper, everyone in Nigel’s facility knows the revenue target, the yield requirements, and how their daily work connects to both. Whiteboards, KPI dashboards, and daily leadership stand-ups create complete congruence across the organisation. Cultivation targets and company targets are the same thing.
Leading by Example, Not by Title
Nigel’s philosophy on leadership is practical and unambiguous: be present, ask real questions, and absorb accountability when things go wrong. One of his senior leaders voluntarily cleaned the change rooms; staff started joining in without being asked. That, Nigel says, is what real leadership looks like.
Genetics Selection for Commercial Cultivation
Before any cultivar enters a production system, the first question is whether the market will want it. Potency thresholds are climbing, with 30% THC becoming a standard benchmark. Terpene diversity, organic visual appeal, EU Pharmacopoeia-compliant flower structure, and hermaphrodite stability under stress are all critical screening filters. Trials must come before commercial production, every time.
Debunking Cultivation Myths
Nigel works through several of the industry’s most debated topics. On flushing: it mimics what happens naturally in a temperate autumn, reduces salt stress in the root zone, and saves on nutrients. Skipping it makes no agronomic sense. On micro seeds: most cases point to late-stage stress triggering rogue anthers, and genetics that do this consistently should be screened out. On hang drying versus rack drying: the drying room’s temperature, humidity, and airflow uniformity matter far more than the method. On curing: it is a gas exchange and biosynthetic process that begins at harvest and continues through every stage the flower is opened, handled, and resealed.
Tissue Culture in Cannabis: Promising but Not the Workhorse
Cannabis propagates so well from stem cuttings that tissue culture has never displaced the mother room in most commercial operations. Its greatest commercial utility today is as a germplasm bank and a tool for refreshing clean mother stock, though genetic drift can still occur. Stable F1 seed lines are emerging as a parallel solution to the same propagation challenges.
Hiring Philosophy for Cultivation Teams
Cultivation leadership roles demand real talent. Experienced growers with deep instincts are invaluable on the grow floor, but a regulated EU GMP environment also demands documentation discipline, quality assurance readiness, and the ability to have work questioned without taking it personally. Building a team means building a system that can sustain itself, and that means encouraging leaders at every level to lead.
Top Quotes from Nikita and Nigel
"As a scientist, this [cannabis] is the most interesting plant that we know nothing about."
“Understanding your customer and then reverse engineering from there makes a hell of sense.”
"Sex expression in cannabis is controlled by 200 genes. I often joke some kushes you can look at the wrong way and get male anthers next week.
"Finding the right genetics for the market was something that was forgotten for a long time."
"Cannabis is actually masquerading around as a tree. It's a woody plant that has woody features, but it's an annual herbaceous plant and it's not supposed to live indefinitely. Yet you can grow mothers technically for for years and years."
"Really went full circle from getting kicked out of school to starting Europe's first recruitment agency for the cannabis market."
"One person can't do everything. You have to build the system to self-sustain."
"Just because it's cannabis doesn't mean we have to forgo normal business doctrine of company needs to have a product that customers want. In this case, it's a medical patient. It's still a customer and that product has to fit the market for that customer."
English (UK)
Deutsch